Hospital
Midwest Division-Oprmc LLC
Midwest Division-Oprmc LLC was paid $2.62M by Medicaid between Jan 2018 and Nov 2024, across 61 billing codes. Its largest line is 99283, emergency room visit (moderate) — 56% of everything it billed.
33Billing provider infoMIDWEST DIVISION-OPRMC LLC
OVERLAND PARK, KS 66215
OVERLAND PARK, KS 66215
33aNPI1578500484assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.62M
24GClaims43,396
24DCodes billed61
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Kansas
Rank by total paid#11 of 48
Median peer was paid$461K
This provider vs. median5.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,787 | $418K | |
| 2019 | 3,893 | $391K | |
| 2020 | 1,526 | $110K | |
| 2021 | 5,017 | $260K | |
| 2022 | 8,628 | $540K | |
| 2023 | 9,018 | $537K | |
| 2024incomplete | 5,527 | $367K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 56% | 17,672 | 16,818 | $1.48M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 7,342 | 6,816 | $728K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.1% | 2,765 | 2,660 | $187K |
| 85027 | 2.0% | 5,644 | 5,021 | $52K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 604 | 576 | $28K |
| 80053 | Comprehensive metabolic panel | 1.0% | 2,190 | 1,974 | $26K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 215 | 190 | $25K |
| G0378 | Hospital observation service, per hour | <1% | 249 | 132 | $23K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 991 | 922 | $19K |
| 83735 | <1% | 139 | 98 | $9K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 76 | 74 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 117 | 94 | $5K |
49 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 344 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 131 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 78 | $3K |
| 87430 | <1% | 375 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 94 | $2K |
| 84484 | <1% | 149 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 42 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 42 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 174 | $1K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 16 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 99 | $1K |
| 81025 | <1% | 195 | $1K | |
| 87428 | <1% | 55 | $1K | |
| 87081 | <1% | 172 | $959.14 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 116 | $876.71 |
| 83880 | <1% | 54 | $834.35 | |
| 82553 | <1% | 72 | $804.35 | |
| 71045 | Radiologic examination, chest; single view | <1% | 199 | $789.17 |
| 83690 | <1% | 124 | $702.05 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 26 | $666.33 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 58 | $643.82 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,131 | $540.29 |
| 81001 | <1% | 220 | $529.20 | |
| 82550 | <1% | 74 | $454.44 | |
| 84703 | <1% | 66 | $427.06 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 49 | $398.16 |
| 87807 | <1% | 32 | $317.98 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $250.80 |
| 85379 | <1% | 34 | $248.75 | |
| 74018 | <1% | 35 | $243.18 | |
| 85610 | <1% | 65 | $209.50 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 100 | $187.72 |
| 80306 | <1% | 14 | $176.69 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $161.45 |
| 81003 | <1% | 255 | $158.48 | |
| 85730 | <1% | 48 | $155.98 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 160 | $125.22 |
| 86850 | <1% | 14 | $86.66 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 31 | $69.74 |
| 86901 | <1% | 14 | $67.18 | |
| 86900 | <1% | 14 | $52.75 | |
| 87210 | <1% | 12 | $44.74 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 39 | $36.95 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 16 | $28.39 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 19 | $18.45 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 73 | $6.67 |
| A9270 | Non-covered item or service | 0% | 118 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 71 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHEURTIN, JOHN (CFO)